#5449 on the rich list of 14,452 insiders
John R. Stuelpnagel
Director at 10x Genomics. Based in Pleasanton, California.
$18.8M
in disclosed stock, +$102K (+0.54%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 5449th of 14,452
- Companies held
- 1
- Largest holding
- TXG, 100.0% of total
- Latest SEC filing
- Sep 3, 2026
What the $18.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| 10x Genomics TXG Class A Common Stock | Directly | 328,436 | $57.38 | $18.8M | 100.0% | Form 4, Sep 3, 2026 |
Share counts are the amounts John R. Stuelpnagel reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 5446 | Patrick Waite President & COO, Equity LifeStyle Properties. Chicago, IL | $18.9M |
| 5447 | Cameron Brooks CHIEF REVENUE OFFICER, Axon Enterprise. Scottsdale, AZ | $18.8M |
| 5448 | Jonathan Clark EVP, CFO & Treasurer, Encore Capital Group. San Diego, CA | $18.8M |
| 5449 | John R. Stuelpnagel Director, 10x Genomics. Pleasanton, CA | $18.8M |
| 5450 | Samuel Gibson Chief Executive Officer, Hadron Energy. Redwood City, CA | $18.8M |
| 5451 | Michael L. Gravelle EVP, General Counsel, Fidelity National Financial. Jacksonville, FL | $18.8M |
| 5452 | Kathleen Wilson-Thompson Director, Tesla. Irving, TX | $18.8M |
Other 10x Genomics insiders
All TXG insiders- Serge Saxonov$249MChief Executive Officer. #763 overall
- Bryan E. Roberts$28.7MDirector. #3921 overall
- Benjamin J. Hindson$28.0MSee Remarks. #3994 overall
- Adam Taich$18.2MChief Financial Officer. #5591 overall
- Mathai Mammen$10.3MDirector. #4893 overall
- Justin J. McAnear$8.2MInsider. #9282 overall
Questions
How much stock does John R. Stuelpnagel own?
John R. Stuelpnagel holds $18,845,658 in listed stock based on SEC filings and current prices, mostly 10x Genomics (TXG). That ranks 5449th on the Stock Rich List.
Is this John R. Stuelpnagel's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John R. Stuelpnagel last buy or sell stock?
The most recent open-market trade on file is a sale of 6,814 TXG shares on Sep 3, 2026 at $62.11.